PMC:7074424 / 28640-28979
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
666 | 121-130 | Chemical | denotes | Vitamin C | MESH:D001205 |
667 | 132-143 | Chemical | denotes | favipiravir | MESH:C462182 |
668 | 145-155 | Chemical | denotes | adalimumab | MESH:D000068879 |
669 | 157-188 | Chemical | denotes | dihydro-artemisinin piperaquine | |
670 | 190-201 | Chemical | denotes | leflunomide | MESH:D000077339 |
671 | 203-215 | Chemical | denotes | dipyridamole | MESH:D004176 |
672 | 217-228 | Chemical | denotes | chloroquine | MESH:D002738 |
673 | 232-250 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
674 | 252-266 | Chemical | denotes | suramin sodium | MESH:D013498 |
675 | 268-287 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
676 | 292-299 | Chemical | denotes | arbidol | MESH:C086979 |
677 | 301-311 | Chemical | denotes | umifenovir | MESH:C086979 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T910 | 10-36 | CHEBI:52217;CHEBI:52217 | denotes | pharmacotherapeutic agents |
T909 | 121-130 | CHEBI:21241;CHEBI:21241 | denotes | Vitamin C |
T907 | 145-155 | CHEBI:28748;CHEBI:28748;DG_1 | denotes | adalimumab |
T906 | 157-164 | CHEBI:50488;CHEBI:50488 | denotes | dihydro |
T905 | 177-188 | CHEBI:17939;CHEBI:17939 | denotes | piperaquine |
T904 | 190-201 | CHEBI:6402;CHEBI:6402 | denotes | leflunomide |
T903 | 203-215 | CHEBI:4653;CHEBI:4653 | denotes | dipyridamole |
T902 | 217-228 | CHEBI:3638;CHEBI:3638;DG_10 | denotes | chloroquine |
T901 | 232-250 | CHEBI:5801;CHEBI:5801;DG_20 | denotes | hydroxychloroquine |
T900 | 268-277 | DG_23 | denotes | lopinavir |
T899 | 278-287 | DG_30 | denotes | ritonavir |
T898 | 292-299 | DG_49 | denotes | arbidol |
T897 | 301-311 | DG_49 | denotes | umifenovir |
T896 | 326-338 | PR:000008915 | denotes | IFN-alpha 2b |
T908 | 132-143 | CHEBI:119915;CHEBI:119915;DG_17;NCBITaxon:31032 | denotes | favipiravir |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T361 | 121-130 | Chemical | denotes | Vitamin C | http://purl.obolibrary.org/obo/CHEBI_21241|http://purl.obolibrary.org/obo/CHEBI_29073|http://purl.obolibrary.org/obo/CHEBI_38290 |
T364 | 121-128 | Chemical | denotes | Vitamin | http://purl.obolibrary.org/obo/CHEBI_33229 |
T365 | 132-143 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
T366 | 157-176 | Chemical | denotes | dihydro-artemisinin | http://purl.obolibrary.org/obo/CHEBI_135921|http://purl.obolibrary.org/obo/CHEBI_207229 |
T368 | 165-176 | Chemical | denotes | artemisinin | http://purl.obolibrary.org/obo/CHEBI_223316 |
T369 | 177-188 | Chemical | denotes | piperaquine | http://purl.obolibrary.org/obo/CHEBI_91231 |
T370 | 190-201 | Chemical | denotes | leflunomide | http://purl.obolibrary.org/obo/CHEBI_6402 |
T371 | 203-215 | Chemical | denotes | dipyridamole | http://purl.obolibrary.org/obo/CHEBI_4653 |
T372 | 217-228 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T373 | 232-250 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T374 | 252-259 | Chemical | denotes | suramin | http://purl.obolibrary.org/obo/CHEBI_45906 |
T375 | 260-266 | Chemical | denotes | sodium | http://purl.obolibrary.org/obo/CHEBI_26708 |
T376 | 268-287 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
T377 | 268-277 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T378 | 278-287 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T379 | 292-299 | Chemical | denotes | arbidol | http://purl.obolibrary.org/obo/CHEBI_134730 |
T380 | 301-311 | Chemical | denotes | umifenovir | http://purl.obolibrary.org/obo/CHEBI_134730 |
T381 | 326-329 | Chemical | denotes | IFN | http://purl.obolibrary.org/obo/CHEBI_52999 |
T382 | 330-335 | Chemical | denotes | alpha | http://purl.obolibrary.org/obo/CHEBI_30216 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T175 | 0-339 | Sentence | denotes | Among the pharmacotherapeutic agents evaluated, some of the highlighted agents, which are being evaluated, are high-dose Vitamin C, favipiravir, adalimumab, dihydro-artemisinin piperaquine, leflunomide, dipyridamole, chloroquine or hydroxychloroquine, suramin sodium, lopinavir/ritonavir and arbidol (umifenovir) tablets, and IFN-alpha 2b. |